Globus Medical (NYSE:GMED) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of…
Globus Medical (NYSE:GMED) reported quarterly earnings results on February 24, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $1.28, beating the consensus estimate of $1.12 by $0.16 per share. Revenue came in at $826.4M, beating the estimate of $797.1M.
Globus Medical's stock moved following the earnings release. The stock currently trades at $94.06 with a market capitalization of $11.9B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NYSE · GMED
$80.48
Up: +$1.22 · +1.51%
Live quote updated
Keep reading
analyst ·
analyst ·
analyst ·
analyst ·
